Cargando…

Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy

INTRODUCTION: Despite a systematic increase in the coverage of patients with end-stage renal disease (ESRD) who have received dialytic therapies and transplantation over the past 2 decades, the Mexican health system currently still does not have a program to provide full coverage of ESRD. Our aim wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdez-Ortiz, Rafael, Navarro-Reynoso, Francisco, Olvera-Soto, Ma Guadalupe, Martin-Alemañy, Geovana, Rodríguez-Matías, Adrian, Hernández-Arciniega, Clara Rocío, Cortes-Pérez, Mario, Chávez-López, Ernesto, García-Villalobos, Gloria, Hinojosa-Heredia, Héctor, Camacho-Aguirre, Ana Yetzin, Valdez-Ortiz, Ángel, Cantú-Quintanilla, Guillermo, Gómez-Guerrero, Irma, Reding, Arturo, Pérez-Navarro, Monserrat, Obrador, Gregorio, Correa-Rotter, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127451/
https://www.ncbi.nlm.nih.gov/pubmed/30197984
http://dx.doi.org/10.1016/j.ekir.2018.06.004
Descripción
Sumario:INTRODUCTION: Despite a systematic increase in the coverage of patients with end-stage renal disease (ESRD) who have received dialytic therapies and transplantation over the past 2 decades, the Mexican health system currently still does not have a program to provide full coverage of ESRD. Our aim was to analyze mortality in patients with ESRD without health insurance. METHODS: This was a prospective cohort study of 850 patients with advanced chronic kidney disease (CKD). Risk factors associated with death were calculated using a Cox's proportional hazards model. We used the statistical package SPSS version 22.0 for data analysis. RESULTS: The mean age of patients was 44.8 ± 17.2 years old. At the time of hospital admission, 87.6% of the population did not have a social security program to cover the cost of renal replacement treatment, and 91.3% of families had an income below US$300 per month. During the 3 years of the study, 28.8% of the cohort patients were enrolled in 1 of Mexico's social security programs. The 3-year mortality rate was of 56.7% among patients without access to health insurance, in contrast to 38.2% of patients who had access to a social security program that provided access to renal replacement therapy (P < 0.001). Risk factor analysis revealed that not having health insurance increased mortality (risk ratio: 2.64, 95% confidence intervals: 1.84−3.79; P = 0.001). CONCLUSION: Mexico needs a coordinated National Kidney Health and Treatment Program. A program of this nature should provide the basis for an appropriate educational and intervention strategy for early detection, prevention, and treatment of patients with advanced chronic kidney disease.